Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Escalation Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease

NCT00100282 is registered in ClinicalTrials.gov with PRAECIS Pharmaceuticals Inc. as lead sponsor.

NCT NCT00100282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Escalation Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease
Lead sponsor
PRAECIS Pharmaceuticals Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2003
Completion date
June 30, 2005
Enrollment
125
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease